Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...

Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, a study shows.

People who develop MS begin using healthcare services more frequently up to 15 years before their MS symptoms first appear.

The experimental CAR T-cell therapy treatment was given as part of a clinical trial that's enrolling adults with progressive ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow ...

Medications that promote repair of the myelin sheath that protects nerve cells may help limit damage due to MS, a trial ...

Columnist Desiree Lama describes her unexpected joy at having a new cat join her existing feline friend, especially when they ...

Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...